BamSEC and AlphaSense Join Forces
Learn More

Allergan Plc

Formerly NYSE: AGN
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 10-Q/A 4 pages January 15, 2018 Mr. Matthew M. Walsh [Redacted] Dear Matt,
12/34/56
EX-10.1
from 10-Q 9 pages Execution Version Separation Agreement and Release
12/34/56
EX-10.49
from 10-K 6 pages Consulting Agreement
12/34/56
EX-10.48
from 10-K 18 pages Separation Agreement and Release
12/34/56
EX-10.1
from 10-Q 17 pages Allergan Plc 2017 Executive Severance Plan (Effective July 20, 2017) Allergan Plc 2017 Executive Severance Plan
12/34/56
EX-10.1
from 10-Q 11 pages Notice of Grant
12/34/56
EX-10.2
from 10-Q 28 pages The Amended and Restated 2013 Incentive Award Plan of Allergan Plc
12/34/56
EX-10.1
from 10-Q 37 pages Amended and Restated Allergan Plc 2011 Incentive Award Plan Article 1 Purpose
12/34/56
EX-10.1
from 8-K 13 pages Exhibit 1-A A&R Other Cash-Based Award Agreement
12/34/56
EX-10.1
from 8-K 7 pages Termination Agreement
12/34/56
EX-10.4
from 10-Q 13 pages Material contract
12/34/56
EX-10.3
from 10-Q 13 pages Material contract
12/34/56
EX-10.1
from 8-K 27 pages Amended and Restated Stockholder Voting Agreement
12/34/56
EX-10.1
from 425 27 pages Amended and Restated Stockholder Voting Agreement
12/34/56
EX-10.1
from 8-K 34 pages Form of Stockholders Agreement
12/34/56
EX-10.1
from 8-K 26 pages Stockholder Voting Agreement
12/34/56
EX-10.1
from 425 26 pages Stockholder Voting Agreement
12/34/56
EX-10.52
from 10-Q 65 pages Asset Purchase Agreement by and Among Forest Laboratories, LLC, Forest Laboratories Canada Inc., and Forest Laboratories Holdings Limited as Sellers, Actavis PLC, and Astrazeneca Uk Limited, as Purchaser Dated as of February 4, 2015
12/34/56
EX-10.40
from 10-Q 5 pages You Have Been Identified as a Key Contributor to the Success of Actavis PLC, Its Subsidiaries and Affiliates (The “Company”) and the Success of Its Pending Acquisition of Forest Laboratories, Inc. (The “Forest Transaction”). in Recognition of Your Contributions, the Company Is Pleased to Offer You a Special Retention, as Set Forth Below, Which Is Contingent Upon Your Acceptance of the Terms of This Letter. Special Retention Award
12/34/56
EX-10.39
from 10-Q 9 pages Consulting Agreement
12/34/56